Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2004-04-12
2008-09-16
Seaman, D. Margaret (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C548S530000, C548S557000, C549S051000, C549S058000, C549S059000
Reexamination Certificate
active
07425631
ABSTRACT:
Selected compounds are effective for treatment of pain and diseases, such as inflammation mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving pain, inflammation, and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
REFERENCES:
patent: 0035868 (1981-09-01), None
patent: WO 92/12140 (1992-07-01), None
patent: WO 97/25315 (1997-07-01), None
patent: WO 02/06222 (2002-01-01), None
patent: WO 02/076964 (2002-10-01), None
patent: WO 2004/054584 (2004-07-01), None
patent: WO 2004/083173 (2004-09-01), None
Jessell et al., “Pain and Analgesia” inPrinciples of Neural Science, 3rdEdition, 1991, E.R. Kandel, J.H. Schwartz, T.M. Jessell, editors, pp. 385-399.
M.J. Millan, “The Induction of Pain: An Integrative Review,”Prog. Neurobiol., 1999, 57:1-164.
Regoli et al., “Pharmacology of Bradykinin and Related Kinins,”Pharmacological Rev., 1980, 32(1):1-46.
Menke et al., “Expression Cloning of a Human B1Bradykinin Receptor,”J. Biol. Chem., 1994, 269:21583-21586.
Hess et al., “Cloning and Pharmacological Characterization of a Human Bradykinin (BK-2) Receptor,”Biochem. Biophys. Res. Commun., 1992, 184:260-268.
F. Marceau et al., “Kinin B1receptors: a review,”Immunopharmacology, 1995, 30:1-26.
E.J. Corey et al., “Highly Enantioselective Borane Reduction of Ketones Catalyzed by Chiral Oxazaborolidines. Mechanism and Synthetic Implications,”J. Am. Chem. Soc., 1987, v. 109, pp. 5551-5553.
T. Ohkuma et al., “Practical Enantioselective Hydrogenation of Aromatic Ketones,”J. Am. Chem Soc., 1995, v. 117, pp. 2575-2676.
Thompson et al., “Direct Conversion of Activated Alcohols to Azides Using Diphenyl Phosphoroazidate. A Practical Alternative to Mitsunobu Conditions,”J. Org. Chem., 1993, 58 (22):5886-5888.
DG Batt et al., “Disubstituted Indazoles as Potent Antagonists of the Integrin αvβ3,”Journal of Medicinal Chemistry, 2000, 43:41-58.
G. Wagner et al., “Synthesis of 3-(p- and m-amidinophenyl-3-arylsulfonylaminopropionic acid amide hydroiodides,”Chemical Abstracts, Mar. 29, 1982, 96(13), abstract No. 104710e.
G. Wagner et al., “Synthese von 3-(p- und m-Amidinophenyl)-3-arylsulfonylaminopropionsäureamidhydroiodiden,”Pharmazie, 1981, 36(9):607-609.
Askew, Jr. Benny C.
Biswas Kaustav
Chen Jian Jeffrey
D'Amico Derin C.
Fotsch Christopher H.
Amgen Inc.
Array BioPharma Inc.
McDonnell & Boehnen Hulbert & Berghoff
Seaman D. Margaret
LandOfFree
Compounds and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds and methods of use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3983839